4-HO-MPMI
- (R)-3-(N-methylpyrrolidin-2-ylmethyl)-4-hydoxyindole
- 250672-65-2 Y
- 10466404
- 8641815 N
- 46OU9HLZ35
- DTXSID80440389
- Interactive image
- OC1=C2C(C[C@@]3([H])CCCN3C)=CNC2=CC=C1
- InChI=1S/C14H18N2O/c1-16-7-3-4-11(16)8-10-9-15-12-5-2-6-13(17)14(10)12/h2,5-6,9,11,15,17H,3-4,7-8H2,1H3/t11-/m1/s1 N
- Key:XYRKPZYRLSWABB-LLVKDONJSA-N N
4-HO-MPMI (also known as 4-Hydroxy-N-methyl-(α,N-trimethylene)-tryptamine or lucigenol) is a tryptamine derivative that is a psychedelic drug. It was developed by the team led by David Nichols from Purdue University in the late 1990s. This compound produces hallucinogen-appropriate responding in animal tests with a similar potency to the amphetamine-derived psychedelic DOI, and has two enantiomers, with only the (R)-enantiomer being active.[1]
The binding affinity for 5-HT2A receptor is 13 ± 2 nM (Ki [125I]DOI). It is reported at doses starting at 0.5 mg and 1.0-1.5 mg seem to be psychedelic doses. The duration it is reported between six and eight hours. The effects, still not too documented, are OEV/CEV, sedation and anxiety.[2][unreliable source?]
See also
References
- ^ Gerasimov M, Marona-Lewicka D, Kurrasch-Orbaugh DM, Qandil AM, Nichols DE (1999). "Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain". Journal of Medicinal Chemistry. 42 (20): 4257–4263. CiteSeerX 10.1.1.690.4941. doi:10.1021/jm990325u. PMID 10514296.
- ^ "Lucigenol Info - Hip Forums". Archived from the original on 2011-07-11. Retrieved 2010-08-02.
- v
- t
- e
(5-HT2A
agonists)
Benzofurans | |||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lyserg‐ amides |
| ||||||||||||||||||||||||||||||||||||||||
Phenethyl‐ amines |
| ||||||||||||||||||||||||||||||||||||||||
Piperazines | |||||||||||||||||||||||||||||||||||||||||
Tryptamines |
| ||||||||||||||||||||||||||||||||||||||||
Others |
|
(NMDAR
antagonists)
Arylcyclo‐ hexylamines |
| ||||||
---|---|---|---|---|---|---|---|
Adamantanes | |||||||
Diarylethylamines | |||||||
Morphinans | |||||||
Others |
(mAChR
antagonists)
- Atropine
- Benactyzine
- Benzatropine
- Benzydamine
- Biperiden
- BRN-1484501
- Brompheniramine
- BZ
- CAR-226,086
- CAR-301,060
- CAR-302,196
- CAR-302,282
- CAR-302,368
- CAR-302,537
- CAR-302,668
- Chloropyramine
- Chlorphenamine
- Clemastine
- CS-27349
- Cyclizine
- Cyproheptadine
- Dicycloverine
- Dimenhydrinate
- Diphenhydramine
- Ditran
- Doxylamine
- EA-3167
- EA-3443
- EA-3580
- EA-3834
- Flavoxate
- Hyoscyamine
- JB-318
- JB-336
- Meclozine
- Mepyramine
- Orphenadrine
- Oxybutynin
- Pheniramine
- Phenyltoloxamine
- Procyclidine
- Promethazine
- Scopolamine
- Tolterodine
- Trihexyphenidyl
- Tripelennamine
- Triprolidine
- WIN-2299